
|Videos|January 26, 2022
What brexpiprazole brings to the treatments for schizophrenia in pediatric patients
Author(s)Miranda Hester
Abigail Donovan, MD, discusses what brexpiprazole can do for treating schizophrenia in older children.
Advertisement
Contemporary Pediatrics sat down with Abigail Donovan, MD, assistant professor of psychiatry at Massachusetts General Hospital in Boston to discuss brexpiprazole, which recently received a supplemental new drug application from the US Fod and Drug Administration for use in patients aged 13 to 17 years. She discussed what it brings to the table, the adverse effects it can cause, and who is likely to prescribe it.
Newsletter
Access practical, evidence-based guidance to support better care for our youngest patients. Join our email list for the latest clinical updates.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Contemporary Pediatrics
1
Phase 3 trial meets primary endpoint for VIASKIN Peanut patch in children aged 4–7 years
2
19-year-old female with painful, purpuric nodules in the phalanges of her fingers
3
Special Report: Rethinking type 1 diabetes through a screening lense
4
FDA approves depemokimab for severe asthma in patients 12 years and older
5








